Sharon Hemond Hrynkow
CIK 1745677 · Chief Scientific Officer · last filed 2025-09-11
Sharon Hemond Hrynkow is a Chief Scientific Officer who has filed 18 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for FORD, was dated Sep 11, 2025. Across all open-market trades the lifetime net is +$23.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
18
$23.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Forward Industries, Inc. (FORD) Delisted | Director | 10,000 | $9.48 | $94.8K | $11.3K | 7 | 2025-09-11 |
| Cyclo Therapeutics, Inc. (CYTHW) Delisted | Chief Scientific Officer | 19,350 | $0.03 | $619 | $12.4K | 5 | 2021-12-02 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-11 | Forward Industries, Inc. (FORD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | Forward Industries, Inc. (FORD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-10-02 | Forward Industries, Inc. (FORD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-03 | Forward Industries, Inc. (FORD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | Forward Industries, Inc. (FORD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-21 | Forward Industries, Inc. (FORD) Delisted | Buy (P) | +9,855 | $11.3K | EDGAR |
| 2022-02-18 | Forward Industries, Inc. (FORD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-02 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +1,000 | $5.0K | EDGAR |
| 2021-08-30 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-30 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +1,000 | $7.5K | EDGAR |